---
title: "Abbott Laboratories Stock Underperforms Thursday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297230294.md"
description: "Abbott Laboratories (ABT) shares fell 2.20% to $111.59 on Thursday, marking its third consecutive day of losses and underperforming the broader market, as the S&P 500 rose 0.72%. The stock closed 18.84% below its 52-week high of $137.49. Compared to competitors, Abbott's decline was steeper than Johnson & Johnson (-1.57%) and Pfizer (-0.99%), but slightly better than Merck (-2.33%)."
datetime: "2026-08-27T20:35:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297230294.md)
  - [en](https://longbridge.com/en/news/297230294.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297230294.md)
generator: "portal-rs"
---

# Abbott Laboratories Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Abbott Laboratories (ABT) slid 2.20% to $111.59 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.72% to 7,730.99 and the Dow Jones Industrial Average rising 0.20% to 53,569.44.

This was the stock's third consecutive day of losses.

Abbott Laboratories closed 18.84% short of its 52-week high of $137.49, which the company reached on September 22nd.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) fell 1.57% to $265.77, Pfizer Inc. (PFE) fell 0.99% to $28.02, and Merck & Co. Inc. (MRK) fell 2.33% to $149.54.

Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-27-26 1635ET

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [IFP Advisors Inc Grows Stock Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/298421693.md)
- [Amundi Grows Position in Abbott Laboratories $ABT](https://longbridge.com/en/news/298275328.md)
- [Proficio Capital Partners LLC Makes New $1.10 Million Investment in Abbott Laboratories $ABT](https://longbridge.com/en/news/298128402.md)
- [Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms](https://longbridge.com/en/news/298316210.md)
- [Continuous glucose monitors are about to get more complicated](https://longbridge.com/en/news/297807418.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**